Alerta De Seguridad para Birmingham Hip Modular Heads

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Smith and Nephew.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2012-09-25
  • Fecha de publicación del evento
    2012-09-25
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: smith and nephew birmingham hip modular heads medical device manufacturer, smith and nephew, has issued a field safety notice concerning birmingham hip modular heads. according to the manufacturer, the average revision rate for the birmingham hip modular head with all stems is currently 1.29 revisions per 100 observed component years in the national joint registry of england and wales and 1.12 revisions per 100 observed component years in the australian orthopaedic association’s national joint replacement registry. these rates exceed the 1% benchmark revision rate established by the uk’s national institute for health and clinical excellence. however, if combined with the uncemented synergy stem, the revision rate is 1.07 revisions per 100 observed years which is acceptable and comparable to other clinically successful hip implants on the market. owing to the above reason, the manufacturer has updated the device’s instructions for use (ifu) (lit. no. 81036947 rev d 03/10 for the application of the birmingham hip modular head). a new stand-alone ifu for the affected product is issued, which includes updates on the contraindications, indications and additional warnings. the sections “information on hydroxyapatite implants” and “information on porous coated implants” that are specific to cups have been removed from the ifu. furthermore, the manufacturer advised users to use the affected product only in accordance with the revised indications for use in the revised ifu. according to the local supplier, the affected devices were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 25 september 2012.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Smith and Nephew Birmingham Hip Modular Heads
  • Manufacturer

Manufacturer